Obstetric Interventional Radiology: Periprocedural Considerations When Caring for the Pregnant and Postpartum Patient

Interventional radiology (IR) has had a growing role in the care of pregnant patients over the past few decades. IR is involved in ∼15 per 100,000 pregnancies for the treatment of the placenta accreta spectrum, although there is a variety of procedures that interventional radiologists may perform on a pregnant patient.[1] Caring for this population in the interventional radiology suite can be difficult; positioning considerations, physiological changes, and radiation protection for the mother and fetus pose unique challenges. The aim of this review is to concisely summarize current evidence regarding periprocedural care for pregnant and breastfeeding patients and to present a framework for planning obstetric interventions. The overall paucity of high-level data within this broad range of topics limits the ability to perform a strong systematic review of the literature and as such, this article serves as a narrative review.

Publikationsverlauf

Artikel online veröffentlicht:
07. November 2024

• References

• 1 Baldwin HJ, Randall DA, Maher R. et al. Interventional radiology in obstetric patients: a population-based record linkage study of use and outcomes. Acta Obstet Gynecol Scand 2023; 102 (03) 370-377
• 2 Siebert D, et al. ACR–SPR practice parameter for imaging pregnant or potentially pregnant patients with ionizing radiation. ACR 2023
• 3 Lambrecht S, Van De Velde M. Interventional radiology for the obstetric patient. Curr Opin Anaesthesiol 2020; 33 (04) 566-570
• 4 Zhao H, Wang Q, Han M, Xiao X. Current state of interventional procedures to treat pernicious placenta previa accompanied by placenta accreta spectrum: a review. Medicine (Baltimore) 2023; 102 (37) e34770
• 5 Neuman G, Koren G. Safety of procedural sedation in pregnancy. J Obstet Gynaecol Can 2013; 35 (02) 168-173
• 6 Humphries A, Mirjalili SA, Tarr GP, Thompson JMD, Stone P. The effect of supine positioning on maternal hemodynamics during late pregnancy. J Matern Fetal Neonatal Med 2019; 32 (23) 3923-3930
• 7 Guérin C, Reignier J, Richard JC. et al; PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013; 368 (23) 2159-2168
• 8 Tolcher MC, McKinney JR, Eppes CS. et al. Prone positioning for pregnant women with hypoxemia due to coronavirus disease 2019 (COVID-19). Obstet Gynecol 2020; 136 (02) 259-261
• 9 Samanta S, Samanta S, Wig J, Baronia AK. How safe is the prone position in acute respiratory distress syndrome at late pregnancy?. Am J Emerg Med 2014; 32 (06) 687.e1-687.e3
• 10 Primrose A, Roy N, Teo M, Kanagalingam M. Prone positioning of pregnant patients for lumbar spinal surgery. Anaesth Cases 2014; 2: 103-106
• 11 Osmundo Jr GS, Paganotti CF, da Costa RA. et al. Prone positioning: a safe and effective procedure in pregnant women presenting with severe acute respiratory distress syndrome. Vaccines (Basel) 2022; 10 (12) 2182
• 12 Dennis AT, Hardy L, Leeton L. The prone position in healthy pregnant women and in women with preeclampsia - a pilot study. BMC Pregnancy Childbirth 2018; 18 (01) 445
• 13 Kim FJ, da Silva RD, Gustafson D, Nogueira L, Harlin T, Paul DL. Current issues in patient safety in surgery: a review. Patient Saf Surg 2015; 9: 26
• 14 Practice Guidelines for Moderate Procedural Sedation and Analgesia. Practice Guidelines for Moderate Procedural Sedation and Analgesia 2018: A Report by the American Society of Anesthesiologists Task Force on Moderate Procedural Sedation and Analgesia, the American Association of Oral and Maxillofacial Surgeons, American College of Radiology, American Dental Association, American Society of Dentist Anesthesiologists, and Society of Interventional Radiology. Anesthesiology 2018; 128 (03) 437-479
• 15 ACOG Committee Opinion No. ACOG Committee Opinion No. 775: Nonobstetric surgery during pregnancy. Obstet Gynecol 2019; 133 (04) e285-e286
• 16 Kacmar R, Gaiser R. Physiologic changes of pregnancy. In: Chestnut's Obstetric Anesthesia Principles and Practice. Elsevier; 2020: 19-22
• 17 Food and Drug Administration. Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling. Published online December 4, 2014. Accessed June 11, 2024 at: http://federalregister.gov/a/2014-28241
• 18 Bouvet L, Schulz T, Piana F, Desgranges F-P, Chassard D. Pregnancy and labor epidural effects on gastric emptying: a prospective comparative study. Anesthesiology 2022; 136 (04) 542-550
• 19 Reale SC, Bauer ME, Klumpner TT. et al; Multicenter Perioperative Outcomes Group Collaborators. Frequency and risk factors for difficult intubation in women undergoing general anesthesia for cesarean delivery: a multicenter retrospective cohort analysis. Anesthesiology 2022; 136 (05) 697-708
• 20 Cleary EM, Smid MC, Bokat C, Costantine MM, Rood KM. Indicated opioids in pregnancy: guidance on providing comprehensive care. Am J Perinatol 2023; 40 (06) 602-611
• 21 Pacheco LD, Saade GR, Hankins GDV. Mechanical ventilation during pregnancy. Clin Obstet Gynecol 2014; 57: 844-850
• 22 Enato E, Moretti M, Koren G. The fetal safety of benzodiazepines: an updated meta-analysis. J Obstet Gynaecol Can 2011; 33 (01) 46-48
• 23 Dolovich LR, Addis A, Vaillancourt JM, Power JD, Koren G, Einarson TR. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ 1998; 317 (7162) 839-843
• 24 Roberti R, Rocca M, Iannone LF. et al. Status epilepticus in pregnancy: a literature review and a protocol proposal. Expert Rev Neurother 2022; 22 (04) 301-312
• 25 Shin J. Anesthetic management of the pregnant patient: Part 2. Anesth Prog 2021; 68 (02) 119-127
• 26 Chehab MA, Thakor AS, Tulin-Silver S. et al. Adult and pediatric antibiotic prophylaxis during vascular and IR procedures: a Society of Interventional Radiology Practice Parameter Update Endorsed by the Cardiovascular and Interventional Radiological Society of Europe and the Canadian Association for Interventional Radiology. J Vasc Interv Radiol 2018; 29 (11) 1483-1501.e2
• 27 Bookstaver PB, Bland CM, Griffin B, Stover KR, Eiland LS, McLaughlin M. A review of antibiotic use in pregnancy. Pharmacotherapy 2015; 35 (11) 1052-1062
• 28 Lamont HF, Blogg HJ, Lamont RF. Safety of antimicrobial treatment during pregnancy: a current review of resistance, immunomodulation and teratogenicity. Expert Opin Drug Saf 2014; 13 (12) 1569-1581
• 29 Li Y, Zhang C, Huang X, Tang J. Effect of antimicrobial exposure in pregnancy on adverse pregnancy outcomes and admission rate to the neonatal intensive care unit: a multi-center cohort study. Infect Drug Resist 2023; 16: 2441-2451
• 30 Chow AW, Jewesson PJ. Pharmacokinetics and safety of antimicrobial agents during pregnancy. Rev Infect Dis 1985; 7 (03) 287-313
• 31 Yefet E, Salim R, Chazan B, Akel H, Romano S, Nachum Z. The safety of quinolones in pregnancy. Obstet Gynecol Surv 2014; 69 (11) 681-694
• 32 Briggs GGFR. Drugs in Pregnancy and Lactation. Baltimore, MD:: Williams and Wilkins; 2014
• 33 Heikkilä AM. Antibiotics in pregnancy – a prospective cohort study on the policy of antibiotic prescription. Ann Med 1993; 25 (05) 467-471
• 34 Mylonas I. Antibiotic chemotherapy during pregnancy and lactation period: aspects for consideration. Arch Gynecol Obstet 2011; 283 (01) 7-18
• 35 Erić M, Sabo A. Teratogenicity of antibacterial agents. Coll Antropol 2008; 32 (03) 919-925
• 36 Subtil D, Brabant G, Tilloy E. et al. Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial. Lancet 2018; 392 (10160): 2171-2179
• 37 Briggs GG, Towers CV, Forinash AB. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 12th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2021
• 38 Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 189: Nausea and vomiting of pregnancy. Obstet Gynecol 2018; 131 (01) e15-e30
• 39 Abas MN, Tan PC, Azmi N, Omar SZ. Ondansetron compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial. Obstet Gynecol 2014; 123 (06) 1272-1279
• 40 Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A. The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med 2009; 360 (24) 2528-2535
• 41 Magee LA, Mazzotta P, Koren G. Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). Am J Obstet Gynecol 2002; 186 (5, Suppl Understanding): S256-S261
• 42 Cook JL. Epidemiology of opioid use in pregnancy. Best Pract Res Clin Obstet Gynaecol 2022; 85 (Pt B): 12-17
• 43 Tillett J, Kostich LM, VandeVusse L. Use of over-the-counter medications during pregnancy. J Perinat Neonatal Nurs 2003; 17 (01) 3-18
• 44 Choi EY, Jeong HE, Noh Y. et al. Neonatal and maternal adverse outcomes and exposure to nonsteroidal anti-inflammatory drugs during early pregnancy in South Korea: a nationwide cohort study. PLoS Med 2023; 20 (02) e1004183
• 45 Li DK, Ferber JR, Odouli R, Quesenberry C. Use of nonsteroidal antiinflammatory drugs during pregnancy and the risk of miscarriage. Am J Obstet Gynecol 2018; 219 (03) 275.e1-275.e8
• 46 Stanley AY, Durham CO, Sterrett JJ, Wallace JB. Safety of over-the-counter medications in pregnancy. MCN Am J Matern Child Nurs 2019; 44 (04) 196-205
• 47 Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003; 16 (02) 153-168
• 48 Sultan AA, West J, Tata LJ, Fleming KM, Nelson-Piercy C, Grainge MJ. Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study. Br J Haematol 2012; 156 (03) 366-373
• 49 Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005; 106 (02) 401-407
• 50 Scheres LJJ, Bistervels IM, Middeldorp S. Everything the clinician needs to know about evidence-based anticoagulation in pregnancy. Blood Rev 2019; 33: 82-97
• 51 Brancazio LR, Roperti KA, Stierer R, Laifer SA. Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy. Am J Obstet Gynecol 1995; 173 (04) 1240-1245
• 52 American Association of Physicists in Medicine. ( 2019 AAPM position statement on the use of patient gonadal and fetal shielding. Accessed November 5, 2022 at: https://www.aapm.org/org/policies/details.asp?id=2552&type=PS
• 53 Beyer-Westendorf J, Michalski F, Tittl L. et al. Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reporting. Thromb Haemost 2016; 116 (04) 651-658
• 54 American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. 196: Thromboembolism in Pregnancy. Obstet Gynecol 2018; 132 (01) e1-e17
• 55 Leonhardt G, Gaul C, Nietsch HH, Buerke M, Schleussner E. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis 2006; 21 (03) 271-276
• 56 Sattari M, Serwint JR, Levine DM. Maternal implications of breastfeeding: a review for the internist. Am J Med 2019; 132 (08) 912-920
• 57 Mitchell J, Jones W, Winkley E, Kinsella SM. Guideline on anaesthesia and sedation in breastfeeding women 2020: Guideline from the Association of Anaesthetists. Anaesthesia 2020; 75 (11) 1482-1493
• 58 Reece-Stremtan S, Campos M, Kokajko L. Academy of Breastfeeding Medicine. ABM Clinical Protocol #15: Analgesia and anesthesia for the breastfeeding mother, revised 2017. Breastfeed Med 2017; 12 (09) 500-506
• 59 Anderson PO. Anticoagulants and breastfeeding. Breastfeed Med 2017; 12: 77-78
• 60 National Institute of Child Health and Human Development.. Drugs and Lactation Database (LactMed®). Bethesda, MD:: National Institute of Child Health and Human Development; 2006
• 61 Tremblay E, Thérasse E, Thomassin-Naggara I, Trop I. Quality initiatives: guidelines for use of medical imaging during pregnancy and lactation. Radiographics 2012; 32 (03) 897-911
• 62 Beckett KR, Moriarity AK, Langer JM. Safe use of contrast media: what the radiologist needs to know. Radiographics 2015; 35 (06) 1738-1750
• 63 Cova MA, Stacul F, Quaranta R. et al. Radiological contrast media in the breastfeeding woman: a position paper of the Italian Society of Radiology (SIRM), the Italian Society of Paediatrics (SIP), the Italian Society of Neonatology (SIN) and the Task Force on Breastfeeding, Ministry of Health, Italy. Eur Radiol 2014; 24 (08) 2012-2022
• 64 ACR Committee on Drugs and Contrast Media. ACR Manual on Contrast Media. https://www.acr.org/-/media/acr/files/clinical-resources/contrast_media.pdf
• 65 The Application of ALARA for Occupational Exposures. NCRP Statement No. 8, Issued June 8, 1999. National Council on Radiation Protection. Health Phys 2000; 78: 28-29
• 66 McCollough CH, Schueler BA, Atwell TD. et al. Radiation exposure and pregnancy: when should we be concerned?. Radiographics 2007; 27 (04) 909-917 , discussion 917–918
• 67 ACOG Committee Opinion #299: Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol 2004; 104: 647
• 68 Dauer LT, Thornton RH, Miller DL. et al; Society of Interventional Radiology Safety and Health Committee, Cardiovascular and Interventional Radiology Society of Europe Standards of Practice Committee. Radiation management for interventions using fluoroscopic or computed tomographic guidance during pregnancy: a joint guideline of the Society of Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe with Endorsement by the Canadian Interventional Radiology Association. J Vasc Interv Radiol 2012; 23 (01) 19-32
• 69 Osei EK, Faulkner K. Fetal doses from radiological examinations. Br J Radiol 1999; Aug; 72 (860) 773-780 . PMID: 10624343
• 70 Huda W. Review of Radiologic Physics. Philadelphia, PA:: Lippincott Williams & Wilkins;; 2009
• 71 Wakeford R, Tawn EJ. The meaning of low dose and low dose-rate. J Radiol Prot 2010; 30 (01) 1-3